Published in J Am Coll Cardiol on May 11, 2010
Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus. Nat Med (2013) 2.93
Osteoporosis, osteopenia, and atherosclerotic vascular disease. Arch Med Sci (2011) 1.16
Prevention of liver cancer cachexia-induced cardiac wasting and heart failure. Eur Heart J (2013) 1.06
Endothelial cells obtained from patients affected by chronic venous disease exhibit a pro-inflammatory phenotype. PLoS One (2012) 0.97
Genome-wide association study of gene by smoking interactions in coronary artery calcification. PLoS One (2013) 0.90
Plasma concentrations of extracellular matrix protein fibulin-1 are related to cardiovascular risk markers in chronic kidney disease and diabetes. Cardiovasc Diabetol (2013) 0.89
Cardiovascular diseases in older patients with osteoporotic hip fracture: prevalence, disturbances in mineral and bone metabolism, and bidirectional links. Clin Interv Aging (2013) 0.89
Vascular calcification in chronic kidney disease: Pathogenesis and clinical implication. World J Nephrol (2012) 0.86
Osteoprotegerin in Cardiometabolic Disorders. Int J Endocrinol (2015) 0.84
Osteoprotegerin as a marker of atherosclerosis in diabetic patients. Int J Endocrinol (2013) 0.82
Perturbations of circulating levels of RANKL-osteoprotegerin axis in relation to lipids and progression of atherosclerosis in HIV-infected and -uninfected adults: ACTG NWCS 332/A5078 Study. AIDS Res Hum Retroviruses (2013) 0.81
Donor phosphorus levels and recipient outcomes in living-donor kidney transplantation. Clin J Am Soc Nephrol (2011) 0.81
Mobilization of endothelial progenitors by recurrent bacteremias with a periodontal pathogen. PLoS One (2013) 0.80
The role of osteoprotegerin (OPG) receptor activator for nuclear factor kappaB ligand (RANKL) in cardiovascular pathology - a review. Wien Med Wochenschr (2011) 0.80
Osteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor gene. Am J Pathol (2013) 0.79
Osteoprotegerin inhibits calcification of vascular smooth muscle cell via down regulation of the Notch1-RBP-Jκ/Msx2 signaling pathway. PLoS One (2013) 0.79
Postexercise phosphocreatine recovery, an index of mitochondrial oxidative phosphorylation, is reduced in diabetic patients with lower extremity complications. J Vasc Surg (2013) 0.79
Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease. Biomed Res Int (2016) 0.79
Regression of vascular calcification in chronic kidney disease - feasible or fantasy? a review of the clinical evidence. Br J Clin Pharmacol (2013) 0.78
Acute Myocardial Infarction and Pulmonary Diseases Result in Two Different Degradation Profiles of Elastin as Quantified by Two Novel ELISAs. PLoS One (2013) 0.78
The alliance of mesenchymal stem cells, bone, and diabetes. Int J Endocrinol (2014) 0.78
Mitral valve endothelial cells secrete osteoprotegerin during endothelial mesenchymal transition. J Mol Cell Cardiol (2016) 0.78
Expression of osteoprotegerin and its ligands, RANKL and TRAIL, in rheumatoid arthritis. Sci Rep (2016) 0.77
Relationship of osteoprotegerin to pulse wave velocity and carotid intima-media thickness in rheumatoid arthritis patients. Z Rheumatol (2016) 0.77
Modulation of TGFbeta 2 levels by lamin A in U2-OS osteoblast-like cells: understanding the osteolytic process triggered by altered lamins. Oncotarget (2015) 0.76
Aliskiren improves vascular smooth muscle function in the skin microcirculation of type 2 diabetic patients with normal renal function. J Renin Angiotensin Aldosterone Syst (2013) 0.75
Relationship of serum osteoprotegerin with arterial stiffness, preclinical atherosclerosis, and disease activity in patients with ankylosing spondylitis. Clin Rheumatol (2016) 0.75
Osteoprotegerin, but Not Receptor Activator for Nuclear Factor-κB Ligand, is Associated With Subclinical Coronary Atherosclerosis in HIV-Infected Men. J Acquir Immune Defic Syndr (2015) 0.75
Identification of Patients Affected by Mitral Valve Prolapse with Severe Regurgitation: A Multivariable Regression Model. Oxid Med Cell Longev (2017) 0.75
Correlation of plasma osteoprotegerin (OPG) and receptor activator of the nuclear factor κB ligand (RANKL) levels with clinical risk factors in patients with advanced carotid atherosclerosis. Med Sci Monit (2012) 0.75
Immediately transcripted genes in various hepatic ischemia models. J Korean Surg Soc (2012) 0.75
Serum osteoprotegerin is associated with pulse pressure in kidney transplant recipients. Sci Rep (2015) 0.75
Correlation between Osteoprotegerin Serum Level and Coronary Calcification Using Coronary Artery Calcium Score in Patient with Moderate-Severe Cardiovascular Risk Factor. Int J Angiol (2017) 0.75
Elevated serum osteoprotegerin may predict peripheral arterial disease after kidney transplantation: a single-center prospective cross-sectional study in Taiwan. PeerJ (2017) 0.75
Plasma levels of sRANKL and OPG are associated with atherogenic cytokines in patients with intermediate cardiovascular risk. Heart Vessels (2017) 0.75
Plasma osteoprotegerin, its correlates, and risk of heart failure: a prospective cohort study. Eur J Epidemiol (2016) 0.75
Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: a multicenter, randomized, double-blind trial. Circulation (2006) 3.99
Risk stratification in uncomplicated type 2 diabetes: prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy. Eur Heart J (2006) 2.74
What is the normal range for N-terminal pro-brain natriuretic peptide? How well does this normal range screen for cardiovascular disease? Eur Heart J (2005) 2.52
Determinants of progression of coronary artery calcification in type 2 diabetes role of glycemic control and inflammatory/vascular calcification markers. J Am Coll Cardiol (2007) 2.29
The pathologic basis of Q-wave and non-Q-wave myocardial infarction: a cardiovascular magnetic resonance study. J Am Coll Cardiol (2004) 1.75
Persistent cognitive depressive symptoms are associated with coronary artery calcification. Atherosclerosis (2010) 1.72
Prevalence of silent myocardial ischemia in asymptomatic individuals with subclinical atherosclerosis detected by electron beam tomography. J Nucl Cardiol (2004) 1.70
Increased volume of epicardial fat is an independent risk factor for accelerated progression of sub-clinical coronary atherosclerosis. Atherosclerosis (2011) 1.48
A randomized trial of exercise treadmill ECG versus stress SPECT myocardial perfusion imaging as an initial diagnostic strategy in stable patients with chest pain and suspected CAD: cost analysis. J Nucl Cardiol (2007) 1.46
Evolving role of cardiac CT in the diagnosis of coronary artery disease. Postgrad Med J (2010) 1.43
Comparison between Tc-99m N-NOET and Tl-201 in the assessment of patients with known or suspected coronary artery disease. J Nucl Cardiol (2004) 1.39
The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects. J Am Coll Cardiol (2006) 1.32
Salivary cortisol responses to mental stress are associated with coronary artery calcification in healthy men and women. Eur Heart J (2009) 1.30
Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5. J Endocrinol (2010) 1.28
Usefulness of left atrial volume as a predictor of mortality in patients with ischemic cardiomyopathy. Am J Cardiol (2004) 1.15
Walking speed and subclinical atherosclerosis in healthy older adults: the Whitehall II study. Heart (2009) 1.13
Cortisol responses to mental stress and the progression of coronary artery calcification in healthy men and women. PLoS One (2012) 1.06
Impact of revascularization and myocardial viability determined by nitrate-enhanced Tc-99m sestamibi and Tl-201 imaging on mortality and functional outcome in ischemic cardiomyopathy. J Nucl Cardiol (2002) 1.06
Socioeconomic status and subclinical coronary disease in the Whitehall II epidemiological study. PLoS One (2010) 0.96
Physical activity, sedentary time, and pericardial fat in healthy older adults. Obesity (Silver Spring) (2012) 0.92
Homocysteine-induced endothelin-1 release is dependent on hyperglycaemia and reactive oxygen species production in bovine aortic endothelial cells. J Vasc Res (2006) 0.90
Regulation of vascular endothelial function by procyanidin-rich foods and beverages. J Agric Food Chem (2010) 0.90
Fructose induces gluconeogenesis and lipogenesis through a SIRT1-dependent mechanism. J Endocrinol (2011) 0.89
A role for increased mRNA stability in the induction of endothelin-1 synthesis by lipopolysaccharide. Biochem Pharmacol (2003) 0.88
The role of non-invasive imaging in the risk stratification of asymptomatic diabetic subjects. Eur Heart J (2005) 0.87
Objectively assessed physical activity, sedentary time, and coronary artery calcification in healthy older adults. Arterioscler Thromb Vasc Biol (2011) 0.87
Endotoxin induced hyperlactatemia and hypoglycemia is linked to decreased mitochondrial phosphoenolpyruvate carboxykinase. Life Sci (2009) 0.87
Independent value of tissue harmonic echocardiography for risk stratification in patients with non-ST-segment elevation acute chest pain. J Am Soc Echocardiogr (2002) 0.86
Etiology and pathophysiology of new-onset heart failure: evaluation by myocardial perfusion imaging. J Nucl Cardiol (2009) 0.83
Cardiac remodelling in the era of aggressive medical therapy: does it still exist? Int J Cardiol (2002) 0.82
Vasodilator stress induces infrequent wall thickening abnormalities compared to perfusion defects in mild-to-moderate coronary artery disease: implications for the choice of imaging modality with vasodilator stress. Echocardiography (2004) 0.82
Psychological distress, cortisol stress response and subclinical coronary calcification. Psychoneuroendocrinology (2011) 0.82
The role of cardiovascular imaging techniques in the assessment of patients with acute chest pain. Nucl Med Commun (2007) 0.81
Radiation dose of CT coronary angiography in clinical practice: objective evaluation of strategies for dose optimization. Eur J Radiol (2011) 0.80
Comparative roles of cardiac CT and myocardial perfusion scintigraphy in the evaluation of patients with coronary artery disease: competitive or complementary. J Nucl Cardiol (2010) 0.80
Comparison of red wine extract and polyphenol constituents on endothelin-1 synthesis by cultured endothelial cells. Clin Sci (Lond) (2002) 0.79
Drinking your health? It's too early to say. Nature (2003) 0.79
Community screening for left ventricular hypertrophy in patients with hypertension using hand-held echocardiography. J Am Soc Echocardiogr (2004) 0.78
Prevalence of coronary artery calcium scores and silent myocardial ischaemia was similar in Indian Asians and European whites in a cross-sectional study of asymptomatic subjects from a U.K. population (LOLIPOP-IPC). J Nucl Cardiol (2011) 0.78
Abnormal myocardial perfusion in the absence of anatomically significant coronary artery disease: implications and clinical significance. J Nucl Cardiol (2009) 0.78
Factor VIIa stimulates endothelin-1 synthesis in TNF-primed endothelial cells by activation of protease-activated receptor 2. Clin Sci (Lond) (2005) 0.77
Inhibitory effect of adrenomedullin on basal and tumour necrosis factor alpha-stimulated endothelin-1 synthesis in bovine aortic endothelial cells is independent of cyclic AMP. Biochem Pharmacol (2002) 0.77
Quantitative measurement of mRNA levels by RT-PCR. Studies of ECE-1 isoforms. Methods Mol Biol (2002) 0.77
The non-invasive assessment of hibernating myocardium in ischaemic cardiomyopathy--a myriad of techniques. Eur J Heart Fail (2003) 0.76
Red wine, chocolate and vascular health: developing the evidence base. Heart (2008) 0.76
Rapid assessment of patients with non-ST-segment elevation acute chest pain: troponins, inflammatory markers, or perfusion imaging? J Nucl Cardiol (2002) 0.76
Evaluation of graft patency by computed tomographic angiography in symptom-free post-coronary artery bypass surgery patients. J Nucl Cardiol (2008) 0.75
Finding the age of the patient's heart. BMJ (2003) 0.75
Antianginal medications and diagnostic accuracy of myocardial perfusion imaging. J Nucl Cardiol (2003) 0.75
Elevated hepatic 11β-hydroxysteroid dehydrogenase type 1 induces insulin resistance in uremia. Proc Natl Acad Sci U S A (2014) 0.75
Setting up a myocardial perfusion scintigraphy service: clinical and business aspects. Heart (2005) 0.75
The importance of the link between coronary artery calcification and myocardial ischemia: a developing argument. J Nucl Cardiol (2007) 0.75
Influence of myocardial ischemia on outcomes in patients with systolic versus non-systolic heart failure. Am J Cardiovasc Dis (2011) 0.75
I-123 MIBG scintigraphy in idiopathic dilated cardiomyopathy: where next? J Nucl Cardiol (2002) 0.75
Effect of imidapril and nifedipine on left ventricular hypertrophy in untreated hypertension. Clin Drug Investig (2005) 0.75
Should we be screening for myocardial hibernation in heart failure? J Nucl Cardiol (2004) 0.75
Varying accuracy of myocardial perfusion SPECT and perfusion cardiac MRI for the detection of critical LMS coronary disease. J Nucl Cardiol (2013) 0.75
Cardiac computed tomography and myocardial perfusion imaging for risk stratification in asymptomatic diabetic patients: a critical review. J Nucl Cardiol (2007) 0.75
The detection of myocardial viability and its clinical implications. Cardiovasc J S Afr (2002) 0.75
Diabetes mellitus: evaluation of patients with known or suspected coronary artery disease and the role played by myocardial perfusion imaging. Nucl Med Commun (2005) 0.75
How should I treat a rupture of the interatrial septum with haemodynamically relevant right-to-left shunt during MitraClip implantation? EuroIntervention (2017) 0.75
Setting up a myocardial perfusion scintigraphy service: clinical and business aspects. Nucl Med Commun (2005) 0.75
Metabolic syndrome: an evolving threat in the genesis of coronary artery disease. J Cardiometab Syndr (2007) 0.75